What is the immediate treatment for a patient with Hyperosmolar Hyperglycemic State (HHS) due to diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Treatment of Hyperosmolar Hyperglycemic State (HHS)

Begin aggressive fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 ml/kg/h immediately, and delay insulin therapy until blood glucose stops falling with fluids alone unless significant ketonemia is present. 1, 2, 3

Initial Assessment and Monitoring (0-60 minutes)

Confirm the diagnosis by checking for:

  • Blood glucose ≥600 mg/dl 4
  • Effective serum osmolality ≥320 mOsm/kg (calculated as: 2[measured Na] + glucose/18) 4
  • Arterial pH >7.3 and bicarbonate ≥15 mEq/l (minimal acidosis) 4
  • Ketones ≤3.0 mmol/L (absent or mild ketonemia) 2

Obtain immediate laboratory studies: arterial blood gases, complete blood count with differential, urinalysis, glucose, BUN, creatinine, electrolytes, and electrocardiogram 4, 1

Calculate corrected serum sodium by adding 1.6 mEq for each 100 mg/dl glucose above 100 mg/dl to assess true sodium status 4, 1

Fluid Resuscitation Strategy

First Hour

  • Start with 0.9% NaCl at 15-20 ml/kg/h to restore intravascular volume and renal perfusion 1, 2
  • This aggressive initial resuscitation is critical even in patients with cardiac or renal compromise, though these patients require more intensive monitoring 4, 1
  • Typical total fluid deficits in HHS are 100-220 ml/kg (average 9 liters) 1, 2, 5

After First Hour (1-6 hours)

Switch fluids based on corrected serum sodium: 4, 1

  • If corrected sodium is normal or elevated: change to 0.45% NaCl at 4-14 ml/kg/h
  • If corrected sodium is low: continue 0.9% NaCl at 4-14 ml/kg/h

An initial rise in measured sodium is expected and normal as glucose falls with fluid therapy alone—this does not indicate need for hypotonic fluids 3

Critical Monitoring Parameters

  • Monitor serum osmolality every 2-4 hours 1, 2
  • Target osmolality reduction of 3-8 mOsm/kg/h to minimize risk of osmotic demyelination syndrome 1, 2, 3
  • Assess hemodynamic status through blood pressure, urine output (target ≥0.5 ml/kg/h), and clinical examination 4, 1, 2
  • Correct estimated fluid deficits within 24-48 hours 4, 1

Insulin Therapy: The Critical Timing Difference

This is where HHS differs fundamentally from DKA: 2, 3

When to START Insulin

  • Withhold insulin initially until blood glucose stops falling with IV fluids alone 2, 3
  • Fluid replacement alone will cause significant glucose decline in HHS 3
  • Exception: Start insulin immediately if significant ketonemia is present (>3.0 mmol/L) 2, 3
  • Early insulin use before adequate fluid resuscitation may be detrimental 3

Insulin Dosing Protocol

Once glucose plateaus with fluids or if ketonemia present: 4

  • Exclude hypokalemia first (K+ must be >3.3 mEq/l before starting insulin) 4
  • Give IV bolus of regular insulin 0.15 units/kg 4
  • Follow with continuous infusion at 0.1 units/kg/h (typically 5-7 units/h in adults) 4
  • Target glucose decline of 50-75 mg/dl/h 4

Glucose Management During Treatment

  • When glucose reaches 300 mg/dl in HHS, add 5-10% dextrose to IV fluids 4, 1
  • Reduce insulin infusion to 0.05-0.1 units/kg/h 4
  • Target glucose 10-15 mmol/L (180-270 mg/dl) in first 24 hours, not normoglycemia 1, 2

Potassium Replacement

Critical timing considerations: 4, 1

  • Do not give potassium if K+ <3.3 mEq/l—correct this first before insulin
  • Once renal function confirmed and K+ known, add 20-30 mEq/l potassium to IV fluids
  • Use 2/3 KCl and 1/3 KPO4 4, 1
  • Continue until patient stable and tolerating oral intake

Special Considerations for Renal or Cardiac Compromise

Patients with renal or cardiac disease require heightened vigilance: 4, 1

  • Monitor serum osmolality more frequently (every 2 hours initially) 4, 1
  • Perform frequent cardiac, renal, and mental status assessments 4, 1
  • Consider central venous pressure monitoring or other hemodynamic assessment 1
  • Watch for fluid overload signs: pulmonary edema, worsening oxygenation, elevated jugular venous pressure 1

Common Pitfalls to Avoid

Osmolality correction too rapid: The most dangerous complication is osmotic demyelination syndrome from dropping osmolality >8 mOsm/kg/h 1, 2, 3

Starting insulin too early: Unlike DKA, premature insulin in HHS before adequate fluid resuscitation may worsen outcomes 2, 3

Using hypotonic fluids too early: An initial rise in measured sodium is expected and appropriate—do not switch to hypotonic fluids based on rising sodium alone 3

Inadequate potassium monitoring: Insulin drives potassium intracellularly, risking life-threatening hypokalemia if not monitored and replaced 4

Resolution Criteria

HHS is resolved when: 2

  • Osmolality <300 mOsm/kg
  • Hypovolaemia corrected (urine output ≥0.5 ml/kg/h)
  • Mental status returned to baseline
  • Blood glucose <15 mmol/L (270 mg/dl)

Transition from IV to Subcutaneous Insulin

When transitioning off IV insulin: 4

  • Administer basal insulin 2-4 hours before stopping IV insulin infusion 4
  • This prevents rebound hyperglycemia and recurrence of metabolic decompensation 4
  • Recent evidence supports adding low-dose basal insulin analog during IV insulin infusion to prevent rebound 4

Underlying Precipitants

Identify and treat simultaneously: 4, 2, 5

  • Infections are the most common precipitant 5
  • Other causes: myocardial infarction, stroke, medications (diuretics, corticosteroids), non-compliance 4, 5, 6
  • Failure to treat underlying causes contributes to the high mortality of HHS 5, 6

References

Guideline

Fluid Management for Hyperosmolar Hyperglycemic State (HHS) with Renal Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of hyperosmolar hyperglycaemic state in adults with diabetes.

Diabetic medicine : a journal of the British Diabetic Association, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyperosmolar hyperglycemic state.

American family physician, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.